Home » Conatus Raises $20 Million for Hepatitis C Studies
Conatus Raises $20 Million for Hepatitis C Studies
San Diego’s Conatus Pharmaceuticals, which specializes in developing drugs for liver disease and cancers, said it closed on a $20 million block of equity funding, which was led by a new investor, AgeChem Venture Fund of Montreal.
Xconomy
Xconomy
Upcoming Events
-
07May
-
14May
-
30May